Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (221-230 of 565) with videos related to

Pageof 57
Sort By:
The Journal of ECT|May 24, 2021
Vagus Nerve Stimulation in Patients Receiving Maintenance Therapy With Electroconvulsive Therapy: A Series of 10 CasesScott T Aaronson, Eric L Goldwaser, Dennis J Kutzer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 14, 2006
The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measuresThomas J Carmody, A John Rush, Ira Bernstein, et al.
Journal of Affective Disorders|December 30, 2022
Temporal multi-step predictive modeling of remission in major depressive disorder using early stage treatment data; STAR*D based machine learning approachHaitham Salem, Tung Huynh, Natasha Topolski, et al.
Alcoholism, Clinical and Experimental Research|August 14, 2009
A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependenceE Sherwood Brown, Thomas J Carmody, Joy M Schmitz, et al.
CNS Drugs|July 15, 2009
STAR*D: revising conventional wisdomA John Rush, Diane Warden, Stephen R Wisniewski, et al.
Medical Care|January 27, 2009
Measuring use and cost of care for patients with mood disorders: the utilization and cost inventoryT Michael Kashner, Michael D Stensland, Lisa Lind, et al.
IEEE Computational Intelligence Magazine|November 24, 2018
Augmentation of Physician Assessments with Multi-Omics Enhances Predictability of Drug Response: A Case Study of Major Depressive DisorderArjun Athreya, Ravishankar Iyer, Drew Neavin, et al.
Journal of Proteome Research|December 25, 2008
Mass spectrometry based targeted protein quantification: methods and applicationsSheng Pan, Ruedi Aebersold, Ru Chen, et al.
Acta Psychiatrica Scandinavica|February 12, 2009
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorderR H Perlis, M Fava, M H Trivedi, et al.
The American Journal of Drug and Alcohol Abuse|September 7, 2019
Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label studyAlex Andaluz, Dustin DeMoss, Cynthia Claassen, et al.
Pageof 57

Showing results (221-230 of 565) with videos related to

Sort By:
Pageof 57
The Journal of ECT|May 24, 2021
Vagus Nerve Stimulation in Patients Receiving Maintenance Therapy With Electroconvulsive Therapy: A Series of 10 CasesScott T Aaronson, Eric L Goldwaser, Dennis J Kutzer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 14, 2006
The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measuresThomas J Carmody, A John Rush, Ira Bernstein, et al.
Journal of Affective Disorders|December 30, 2022
Temporal multi-step predictive modeling of remission in major depressive disorder using early stage treatment data; STAR*D based machine learning approachHaitham Salem, Tung Huynh, Natasha Topolski, et al.
Alcoholism, Clinical and Experimental Research|August 14, 2009
A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependenceE Sherwood Brown, Thomas J Carmody, Joy M Schmitz, et al.
CNS Drugs|July 15, 2009
STAR*D: revising conventional wisdomA John Rush, Diane Warden, Stephen R Wisniewski, et al.
Medical Care|January 27, 2009
Measuring use and cost of care for patients with mood disorders: the utilization and cost inventoryT Michael Kashner, Michael D Stensland, Lisa Lind, et al.
IEEE Computational Intelligence Magazine|November 24, 2018
Augmentation of Physician Assessments with Multi-Omics Enhances Predictability of Drug Response: A Case Study of Major Depressive DisorderArjun Athreya, Ravishankar Iyer, Drew Neavin, et al.
Journal of Proteome Research|December 25, 2008
Mass spectrometry based targeted protein quantification: methods and applicationsSheng Pan, Ruedi Aebersold, Ru Chen, et al.
Acta Psychiatrica Scandinavica|February 12, 2009
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorderR H Perlis, M Fava, M H Trivedi, et al.
The American Journal of Drug and Alcohol Abuse|September 7, 2019
Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label studyAlex Andaluz, Dustin DeMoss, Cynthia Claassen, et al.
Pageof 57